BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
13 results:

  • 1. Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells.
    Liu M; Dong Q; Chen B; Liu K; Zhao Z; Wang Y; Zhuang S; Han H; Shi X; Jin Z; Hui Y; Gu Y
    Br J Cancer; 2023 Oct; 129(8):1339-1349. PubMed ID: 37620409
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesia.
    Huynh J; Leiter U; Garbe C; Shiderova G; Walter V; Eigentler T; Scheu A; Häfner HM; Schnabl SM
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):84-92. PubMed ID: 37611257
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of Prognostic Risk Model of Patients with skin Cutaneous Melanoma Based on TCGA-SKCM Methylation Cohort.
    Yu X; Cong P; Wei W; Zhou Y; Bao Z; Hou H
    Comput Math Methods Med; 2022; 2022():4261329. PubMed ID: 36060650
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study.
    Mandalà M; Rutkowski P; Galli F; Patuzzo R; De Giorgi V; Rulli E; Gianatti A; Valeri B; Merelli B; Szumera-Ciećkiewicz A; Massi D; Maurichi A; Teterycz P; Santinami M
    ESMO Open; 2022 Jun; 7(3):100469. PubMed ID: 35421840
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis.
    Li J; Wang J; Li D; Wen X; Ding Y; Liu X; Jiang H; Huang F; Zhang X
    Dermatol Ther; 2021 Sep; 34(5):e15067. PubMed ID: 34302318
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication.
    Watad A; Kacar M; Bragazzi NL; Zhou Q; Jassam M; Taylor J; Roman E; Smith A; Jones RA; Amital H; Cargo C; McGonagle D; Savic S
    Front Immunol; 2021; 12():610019. PubMed ID: 33679746
    [No Abstract]    [Full Text] [Related]  

  • 7. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal.
    Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N
    Int J Cancer; 2021 Jul; 149(2):287-296. PubMed ID: 33634852
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study.
    Liu Y; Zhang P; Zhang Y; Zheng L; Xu W; Hou D; Kang Z
    Sci Rep; 2021 Jan; 11(1):1293. PubMed ID: 33446816
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Acral lentiginous melanoma: a single-centre retrospective review of four decades in East-Central Europe.
    Csányi I; Houshmand N; Szűcs M; Ócsai H; Kemény L; Oláh J; Baltás E
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2004-2010. PubMed ID: 31989672
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.
    Grazziotin TC; Alarcon I; Bonamigo RR; Carrera C; Potrony M; Aguilera P; Puig-Butillé JA; Brito J; Badenas C; Alós L; Malvehy J; Puig S
    JAMA Dermatol; 2016 Oct; 152(10):1099-1105. PubMed ID: 27579522
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
    Eisfeld AK; Schwind S; Patel R; Huang X; Santhanam R; Walker CJ; Markowitz J; Hoag KW; Jarvinen TM; Leffel B; Perrotti D; Carson WE; Marcucci G; Bloomfield CD; de la Chapelle A
    Sci Signal; 2014 Apr; 7(321):ra36. PubMed ID: 24736457
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Correlation of skin toxicity and hypertension with clinical benefit in advanced hepatocellular carcinoma patients treated with sorafenib.
    Shin SY; Lee YJ
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):837-46. PubMed ID: 24075093
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.
    Velazquez EF; Jungbluth AA; Yancovitz M; Gnjatic S; Adams S; O'Neill D; Zavilevich K; Albukh T; Christos P; Mazumdar M; Pavlick A; Polsky D; Shapiro R; Berman R; Spira J; Busam K; Osman I; Bhardwaj N
    Cancer Immun; 2007 Jul; 7():11. PubMed ID: 17625806
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.